BISTTRY18:19Live
ANGEN Balance Sheet and Financial StatementsAnatolia Tanı ve Biyoteknoloji Ürünleri Araştırma Geliştirme Sanayi ve Ticaret A.Ş.
Main MarketChemicals, Petroleum, Rubber and Plastics
7.590.00 (0.00%)
- Volume
- TRY 55.1M
- Day range
- 7.54 – 8.03
- Previous close
- 7.59
- Market cap
- TRY 1.7B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for ANGEN is 2026/6. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Anatolia Tanı ve Biyoteknoloji Ürünleri Araştırma Geliştirme Sanayi ve Ticaret A.Ş. (ANGEN), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/6 | 229.8M | 41.5M | −67.1M |
| 2026/3 | 181.9M | −20.4M | −145.4M |
| 2025/12 | 230.6M | 969.3K | −73.6M |
| 2025/9 | 105.1M | 30M | −27.8M |
| 2025/6 | 223.1M | 62.9M | −129M |
Frequently Asked Questions
How much profit did ANGEN report in its latest statements?
In the latest period (2026/6) ANGEN reported a net profit of TRY −67.1M, sales of TRY 229.8M and EBITDA of TRY 41.5M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.